Kayfanda
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kayfanda, covering 2025-07-11 to 2025-07-11. Get the full timeline:
Most recent: EMA Authorised: Kayfanda (odevixibat sesquihydrate) — Ipsen Pharma
1 regulatory and trial event tracked for Kayfanda, covering 2025-07-11 to 2025-07-11. Get the full timeline:
Most recent: EMA Authorised: Kayfanda (odevixibat sesquihydrate) — Ipsen Pharma